Q14145 (KEAP1_HUMAN) Homo sapiens (Human)
Kelch-like ECH-associated protein 1 UniProtKBInterProSTRINGInteractive Modelling
624 aa; Sequence (Fasta) ;
4 identical sequences: Pan troglodytes: A0A6D2X5C6, H2QFB9; Pan paniscus: A0A2R9BRR8; Gorilla gorilla gorilla: G3QHR9
It is possible new templates exist for this target since these models were created.
Available Structures
105 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Kelch domain of human KEAP1 bound to Nrf2 peptide, ADEETGEFA |
Heteromer Q16236; | 99.3 | ||||
| Crystal Structure of the Kelch-Neh2 Complex |
Heteromer Q16236; | 100 | ||||
| Crystal Structures of apo Keap1, Keap1-peptide, and Keap1-compound complexes |
Heteromer Q16236; | 100 | ||||
| De novo design and crystallographic validation of antibodies targeting a pre-selected epitope |
Heteromer | 99.65 | ||||
| crystal structure of the KEAP1-NEH2 complex |
Heteromer Q16236; | 99.3 | 4×ACT; | |||
| KEAP1 IN COMPLEX WITH PEPTIDE 8 |
Heteromer Q16236; | 99.3 | 1×ACT; | |||
| Kelch domain of human Keap1 bound to Nrf2 ETGE peptide |
Heteromer Q16236; | 99.3 | ||||
| Kelch domain of human KEAP1 bound to Nrf2 peptide, ADEETGEFL |
Heteromer Q16236; | 99.3 | ||||
| Kelch domain of human KEAP1 bound to Nrf2 peptide, LDEETGEFA |
Heteromer Q16236; | 99.29 | ||||
| Kelch domain of human KEAP1 bound to Nrf2 cyclic peptide, c[BAL-DEETGE] |
Heteromer Q16236; | 99.29 | ||||
| Kelch domain of human KEAP1 bound to Nrf2 linear peptide, Ac-GDPETGE-NH2 |
Heteromer Q16236; | 99.29 | ||||
| Kelch domain of human KEAP1 bound to Nrf2 peptide, ADEETGEAA |
Heteromer Q16236; | 99.29 | 1×SO4; | |||
| Kelch domain of human KEAP1 bound to Nrf2 peptide, LDEETGEAL |
Heteromer Q16236; | 99.29 | 2×SO4; | |||
| Kelch domain of human KEAP1 bound to Nrf2 linear peptide, Ac-(BAla)DPETGE-NH2 |
Heteromer Q16236; | 99.29 | ||||
| Kelch domain of human KEAP1 bound to Nrf2-based cyclic peptide, c[GDEETGE] |
Heteromer Q16236; | 99.29 | ||||
| Kelch domain of human KEAP1 bound to Nrf2 linear peptide, Ac-GDEETGE-NH2 |
Heteromer Q16236; | 100 | ||||
| Crystal structure of human CUL3 N-terminal domain bound to KEAP1 BTB and 3-box |
Heteromer Q13618; | 100 | ||||
| The structure of the F64A, S172A mutant Keap1-BTB domain in complex with SKP1-FBXL17 |
Heteromer P63208; Q9UF56; | 98.46 | ||||
| Structure of a substrate-bound DQC ubiquitin ligase |
Heteromer P63208; Q13616; Q9UF56; | 99.23 | ||||
| STRUCTURE OF KEAP1 KELCH DOMAIN WITH(1S,2R)-2-[(1S)-1-[(1-oxo-2,3-dihydro-1H-isoindol-2-Yl)methyl]-… | homo-3-mer | 99.3 | 3×2FS; 2×ACT; | |||
| Structure of keap1 kelch domain with (1S,2R)-2-{[(1S)-5-methyl-1-[(1-oxo-1,3-dihydro-2H-isoindol-2-… | homo-3-mer | 99.65 | 3×1VX; 10×ACT; | |||
| Structure of keap1 kelch domain with 2-{[(1S)-2-{[(1R,2S)-2-(1H-tetrazol-5-yl)cyclohexyl]carbonyl}-… | homo-3-mer | 99.65 | 3×1VW; 5×ACT; | |||
| Structure of keap1 kelch domain with (1S,2R)-2-{[(1S)-1-[(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)me… | homo-2-mer | 99.65 | 5×ACT; 1×1VV; 1×NA; | |||
| Crystal Structure of the KELCH domain of human KEAP1 | homo-2-mer | 100 | 9×FMT; 4×NA; | |||
| Human Kelch like-ECH Associated Protein 1 (Keap1) | homo-2-mer | 100 | ||||
| crystal structure of a KEAP1 mutant | homo-2-mer | 99.3 | 10×ACT; 1×NA; | |||
| Keap1 - peptide complex | homo-2-mer | 100 | 4×EDO; 7×ACT; 7×NA; | |||
| Keap1 - peptide complex | homo-2-mer | 100 | 10×ACT; 6×EDO; 2×CL; 2×NA; | |||
| KEAP1 in complex with compound 25 | homo-2-mer | 100 | 2×A1H7T; 4×EDO; 1×PO4; | |||
| KEAP1 BTB in complex with compound 23 | homo-2-mer | 100.0 | 2×A1H67; | |||
| Low resolution crystal structure of Keap1-456, a repeat fragment from the human Keap1 beta-propeller | homo-2-mer | 100.0 | ||||
| BTB domain of KEAP1 in complex with CDDO | homo-2-mer | 99.24 | 2×SXJ; | |||
| KEAP1 BTB domain in complex with the covalent activator VVD-065 | homo-2-mer | 99.19 | 2×A1BCT; | |||
| Crystal Structure of Human KEAP1 BTB Domain in Complex with isoxazoline-based inhibitor | homo-2-mer | 99.24 | 2×D8N; | |||
| The Crystal Structure of KEAP1 from Biortus. | homo-2-mer | 99.2 | ||||
| BTB domain of KEAP1 C151W mutant | homo-2-mer | 98.47 | ||||
| Crystal structure of the BTB domain human Keap1 | homo-2-mer | 99.23 | ||||
| Crystal Structure of Human KEAP1 BTB Domain in Complex with Small Molecule TX64014 | homo-2-mer | 100.0 | 2×TX6; | |||
| Crystal structure of Keap1 BTB domain in complex with dimethyl fumarate (DMF) | homo-2-mer | 99.21 | 2×9HB; | |||
| The structure of S172A Keap1-BTB domain | homo-2-mer | 99.22 | ||||
| The structure of F64, S172A Keap1-BTB domain | homo-2-mer | 98.45 | ||||
| The structure of V98A S172A Keap1-BTB domain | homo-2-mer | 98.45 | ||||
| BTB domain of KEAP1 in complex with MEF | homo-2-mer | 99.22 | 2×9J3; | |||
| Crystal Structure of Human KEAP1 BTB Domain in Complex with Small Molecule TX64063 | homo-2-mer | 100.0 | 2×58E; | |||
| Crystal structure of Keap1 in complex with dimethyl fumarate (DMF) | monomer | 95.25 | 3×EOU; 1×ACT; 1×PG5; 2×SO4; | |||
| Optimization Efforts for Identification of Novel Highly Potent Keap1-Nrf2 Protein-Protein Interacti… | monomer | 100 | 1×A1LVC; 1×ACT; 5×SO4; | |||
| Methyl and Fluorine Effects in Novel Orally Bioavailable Keap1/Nrf2 PPI Inhibitor for Treatment of … | monomer | 100 | 1×T6I; 6×SO4; | |||
| Methyl and Fluorine Effects in Novel Orally Bioavailable Keap1/Nrf2 PPI Inhibitor for Treatment of … | monomer | 100 | 1×SIU; 5×SO4; | |||
| Methyl and Fluorine Effects in Novel Orally Bioavailable Keap1/Nrf2 PPI Inhibitor for Treatment of … | monomer | 100 | 1×SGO; 1×DTT; 9×SO4; | |||
| Kelch domain of KEAP1 in complex with a ortho-dimethylbenzene linked cyclic peptide 5 (ortho-WRCDPE… | monomer | 98.97 | 2×SO4; 1×CL; 2×EDO; 1×GOL; 2×NA; | |||
| Kelch domain of KEAP1 in complex with a ortho-dimethylbenzene linked cyclic peptide 4 (ortho-WRCDEE… | monomer | 98.97 | 3×SO4; 3×CL; 4×EDO; 1×GOL; 6×NA; | |||
| Optimization Efforts for Identification of Novel Highly Potent Keap1-Nrf2 Protein-Protein Interacti… | monomer | 100 | 1×A1LVB; 1×ACT; 7×SO4; | |||
| Kelch domain of KEAP1 in complex with a ortho-dimethylbenzene linked cyclic peptide 11 (ortho-WRCNP… | monomer | 98.97 | 2×CL; 4×EDO; 2×GOL; 3×NA; | |||
| Kelch domain of KEAP1 in complex with ortho-dimethylbenzene linked cyclic peptide 3 (ortho-WRCDEETG… | monomer | 98.97 | 4×SO4; 1×CL; 2×GOL; 5×EDO; | |||
| Kelch domain of human KEAP1 bound to Nrf2 cyclic peptide, c[BAL-NPETGE] | monomer | 98.96 | ||||
| Kelch domain of human KEAP1 bound to Nrf2 cyclic peptide, c[GEPETGE] | monomer | 98.96 | ||||
| Kelch domain of human KEAP1 bound to Nrf2-based cyclic peptide, c[LhA-DEETGE] | monomer | 98.96 | ||||
| Kelch domain of human KEAP1 bound to Nrf2 cyclic peptide, c[DhA-GDPETGE] | monomer | 98.96 | ||||
| Kelch domain of human Keap1 bound to small molecule inhibitor fragment: 4-oxo-4H-1-benzopyran-2-car… | monomer | 98.96 | 3×SO4; | |||
| Kelch domain of human KEAP1 bound to Nrf2 cyclic peptide, c[DhA-GDPET(bAla)E] | monomer | 98.96 | ||||
| 1.35 angstrom structure of the Kelch domain of Keap1 | monomer | 99.65 | ||||
| Crystal Structures of apo Keap1, Keap1-peptide, and Keap1-compound complexes | monomer | 100 | ||||
| Crystal structure of the Kelch domain of human Keap1 | monomer | 100 | ||||
| Kelch domain of human KEAP1 bound to Nrf2 cyclic peptide, c[GDPETGE] | monomer | 99.65 | ||||
| Crystal Structure of Keap1 Soaked with Synthetic Small Molecular | monomer | 100 | 1×FUU; | |||
| Crystal Structure of Keap1 in Complex with Synthetic Small Molecular based on a co-crystallization | monomer | 100 | 1×FUU; | |||
| Kelch domain of human KEAP1 bound to Nrf2 cyclic peptide, c[GDEEAGE] | monomer | 98.96 | ||||
| Kelch domain of human KEAP1 bound to Nrf2 cyclic peptide, c[Ahx-DPETGE] | monomer | 98.96 | ||||
| Kelch domain of human KEAP1 bound to Nrf2 cyclic peptide, c[GDPEAGE] | monomer | 98.96 | ||||
| Crystal structure of cpd 15 bound to Keap1 Kelch domain | monomer | 100 | 4×PO4; 2×4ID; | |||
| Crystal structure of the Kelch domain in complex with 11 amino acid peptide (model of the ETGE loop) | monomer | 100 | 1×NA; | |||
| Crystal structure of Keap1 Kelch domain (residues 322-609) in complex with 6k | monomer | 100.0 | 1×GED; | |||
| Crystal structure of N-(4-((4-methoxy-N-(2,2,2-trifluoroethyl)phenyl)sulfonamido)isoquinolin-1-yl)-… | monomer | 99.3 | 1×Q5V; 6×FMT; 1×DMS; 1×NA; | |||
| Keap1 Kelch domain (residues 322-609) in complex with 6i | monomer | 100.0 | 1×GCI; | |||
| Crystal structure of 2,2'-(naphthalene-1,4-diylbis(((4-methoxyphenyl)sulfonyl)azanediyl))diacetamid… | monomer | 100 | 1×41P; | |||
| KEAP1 Kelch domain in complex with Compound 9 | monomer | 100 | 1×GOL; 1×DMS; 2×08A; | |||
| Crystal structure of N-[(4-methoxyphenyl)sulfonyl]-N-(4-{[(4-methoxyphenyl)sulfonyl]amino}naphthale… | monomer | 99.3 | 11×FMT; 1×Q5Y; 3×NA; | |||
| Keap1 - inhibitor complex | monomer | 100 | 1×EDO; 1×GX8; 7×NA; | |||
| Crystal structure of cpd 16 bound to Keap1 Kelch domain | monomer | 98.95 | 1×IQK; | |||
| Keap1 compound complex | monomer | 99.3 | 1×91M; 1×CL; | |||
| Keap1 compound complex | monomer | 99.3 | 1×9IB; 1×CL; | |||
| Crystal structure of Keap1 Kelch domain (residues 322-609) in complex with NXPZ-2 | monomer | 100.0 | 2×GFD; | |||
| Crystal structure of the Keap1 Kelch domain in complex with a tetrapeptide | monomer | 100 | ||||
| Keap1 compound complex | monomer | 99.3 | 1×92I; 1×CL; | |||
| Kelch domain of human KEAP1 bound to Nrf2 cyclic peptide, c[GAEETGE] | monomer | 100 | ||||
| Keap1 macrocycle complex | monomer | 99.3 | 1×Q9E; 1×NA; 1×CL; | |||
| Crystal Structures of apo Keap1, Keap1-peptide, and Keap1-compound complexes | monomer | 100 | 1×12O; | |||
| Keap1 compound complex | monomer | 99.3 | 1×9P0; 1×CL; | |||
| Kelch domain of human KEAP1 bound to Nrf2 cyclic peptide, c[GAPETGE] | monomer | 100 | ||||
| Keap1 compound complex | monomer | 99.3 | 1×8ZL; 1×NA; 1×CL; | |||
| KEAP1 IN COMPLEX WITH COMPOUND 6 | monomer | 99.3 | 1×LQ8; 9×ACT; | |||
| Crystal structure of Keap1 Kelch domain (residues 322-609) in complex with 6e | monomer | 100.0 | 1×GDJ; | |||
| Crystal structure of Keap1_6k | monomer | 100.0 | 1×HB6; | |||
| KEAP1 IN COMPLEX WITH COMPOUND 44 | monomer | 99.3 | 4×ACT; | |||
| Kelch domain of human Keap1 bound to small molecule inhibitor fragment: 4-amino-1,7-dihydro-6H-pyra… | monomer | 99.3 | 3×SO4; 1×1XM; | |||
| KEAP1 Kelch domain in complex with Compound 2 | monomer | 100 | 1×FMT; 1×PKG; | |||
| KEAP1 IN COMPLEX WITH COMPOUND 23 | monomer | 99.3 | 1×LQK; | |||
| Kelch domain of human Keap1 in open unliganded conformation | monomer | 99.29 | 3×SO4; | |||
| Kelch domain of human KEAP1 bound to Nrf2-based cyclic peptide, c[GABA-DPETGE] | monomer | 100 | ||||
| Kelch domain of human KEAP1 bound to Nrf2-based cyclic peptide, c[AVA-DPETGE] | monomer | 100 | ||||
| Kelch domain of human KEAP1 bound to Nrf2-based cyclic peptide, c[BAL-DEETGE] | monomer | 100 | 2×SO4; | |||
| Kelch domain of human Keap1 bound to mutant Nrf2 EAGE peptide | monomer | 99.29 | 1×SO4; | |||
| Kelch domain of human Keap1 bound to inhibitory small molecule fragment: hydroxyphenyl propionic ac… | monomer | 99.29 | 1×HPP; | |||
| BTB domain of KEAP1 in complex with XX3 | monomer | 99.23 | 1×XXT; | |||
| BTB domain of KEAP1 | monomer | 99.23 | ||||
2 SWISS-MODEL models
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 2dyh.1.A | monomer | 0.91 | 96.21 | |||
| 6wcq.1.C | monomer | 0.75 | 99.84 | |||